Idiopathic myelofibrosis with generalized periostitis in a 4-year-old girl

Journal of Pediatric Hematology/Oncology

Volumn 27, Issue 5, 2005, Pages 278-282

  Walia, Mandeep ^a,c   Mehta, Rajesh ^a   Paul, Premila ^a   Saluja, Sumita ^a   Kapoor, Sujala ^b   Sharma, Monika ^a  

^a SAFDARJUNG HOSPITAL   (India)

^b SAFDARJUNG HOSPITAL CAMPUS   (India)

^c NONE   (India)

Author keywords

Children; Idiopathic; Myelofibrosis; Pathophysiology

Indexed keywords

CIPROFLOXACIN; ELECTROLYTE; FERRITIN; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN; HEMOGLOBIN A2; HEMOGLOBIN F; IRON; METHYLPREDNISOLONE; RETICULIN; VANCOMYCIN;

ANTHROPOMETRY; ARTICLE; BLOOD CELL COUNT; BLOOD TRANSFUSION; BONE MARROW BIOPSY; BONE RADIOGRAPHY; CASE REPORT; CLINICAL FEATURE; DEATH; DRUG MEGADOSE; ECHOGRAPHY; ELECTROLYTE BLOOD LEVEL; ELECTROPHORESIS; ERYTHROCYTE SHAPE; EXTRAMEDULLARY HEMATOPOIESIS; FEMALE; FERRITIN BLOOD LEVEL; HOSPITAL INFECTION; HUMAN; IRON BINDING CAPACITY; IRON BLOOD LEVEL; KIDNEY FUNCTION TEST; LEUKOCYTOSIS; LIVER FUNCTION TEST; LONG BONE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MYELOID METAPLASIA; MYELOPHTHISIC ANEMIA; MYELOPROLIFERATIVE DISORDER; PERIOSTITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SEROLOGY; SPLENOMEGALY; THORAX RADIOGRAPHY; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

BONE MARROW; CHILD, PRESCHOOL; FATAL OUTCOME; FEMALE; HUMANS; INDIA; MYELOFIBROSIS; PERIOSTITIS;

EID: 18944363939     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mph.0000164611.79834.5d     Document Type: Article

References (24)

1. Heuck G. Zwei Falle von leukamie mit eigenthumlichem blut-resp knoch en marksbefund. Virchows Arch. 1879;78:475.
2. Cervantes F, Barosi G, Demory JL, et al. Myelofibrosis with myeloid metaplasia in young individuals: disease characteristics, prognostic factors and identification of risk groups. Br J Haematol. 1998;102:648-690.
3. Boxer LA, Camitta BM, Berenberg W, et al. Myelofibrosis-myeloid metaplasia in childhood. Pediatrics. 1975;55:861-865.
4. Barosi G. Myelofibrosis with myeloid metaplasia. Hematol Oncol Clin North Am. 2003;17:1211-1226.
5. Tsukamoto N, Morita K, Machara T, et al. Clonality in chronic myeloproliferative disorders defined by X- chromosome linked probes: demonstarion of heterogeneity in lineage involvement. Br J Haematol. 1994;86:253-258.
6. Reilly JT, Wilson G, Barnett D, et al. Karyotypic and ras gene mutational analysis in idiopathic myelofibrosis. Br J Haematol. 1994;88:575-581.
7. Teferi A. Myelofibrosis with myeloid metaplasia. N Engl J Med. 2000; 342:1255-1265.
8. Le Bousse-Kerdiles MC, Martyre MC. French INSERM Research Network on idiopathic myelofibrosis: involvement of the fibrogenic cytokines, TGF-beta and b-FGF, in the pathogenesis of idiopathic myelofibrosis. Pathol Biol (Paris). 2001;49:153-157.
9. Barosi G. Myelofibrosis with myeloid metaplasia: diagnostic definition and prognostic classification for clinical studies and treatment guidelines. J Clin Oncol. 1999;17:2954-2970.
10. Elliot MA, Yoon SY, Kao P, et al. Simultaneous measurement of serum thrombopoietin and expression of megakaryocyte C-Mpl with clinical and laboratory correlates for myelofibrosis with myeloid metaplasia. Eur J Haematol. 2002;68:175-179.
11. Wang JC, Lang HD, Lichter S, et al. Cytogenetic studies of bone marrow fibroblasts cultured from patients with myelofibrosis and myeloid metaplasia. Br J Haematol. 1992;80:184-188.
12. Mason BA, Kressel BR, Cashdollar MR, et al. Periostitis associated with myelofibrosis. Cancer. 1979;43:1568-1571.
13. Thiele J, Kvasnicka HM, Zankovich R, et al. Early-stage idiopathic (primary) myelofibrosis: current issues of diagnostic features. Leukemia Lymphoma. 2002;43:1035-1041.
14. Reilly JT. Cytogenetics and molecular genetic aspects of idiopathic myelofibrosis. Acta Haematol. 2002;108:113-119.
15. Altura RA, Head DR, Wang WC. Long-term survival of infants with idiopathic myelofibrosis. Br J Haematol. 2000;109:459-462.
16. Sekhar M, Prentice HG, Popat U, et al. Idiopathic myelofibrosis in children. Br J Haematol 1996;93:394-397.
17. Mallouh AA, Rahman SA. Agnogenic myeloid metaplasia in children. Am J Dis Child. 1992;146:965-967.
18. Bonduel M, Sciuccati G, Torres AF, et al. Familial idiopathic myelofibrosis and multiple hemangiomas. Am J Haematol. 1998;59: 175-177.
19. Lau S, Ramsay N, Smith CD, et al. Spontaneous resolution of severe childhood myelofibrosis. J Pediatr. 1981;98:585-588.
20. Dupriez B, Morrel P, Demory JL, et al. Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system. Blood. 1996;88:1013-1018.
21. Guardiola P, Anderson JE, Bandini G, et al. Allogenic stem cell transplantation for agnogenic myeloid metaplasia: a European Group for Blood and Marrow Transplantation, Societe Francaise De Greffe de Moelle, Gruppo Italiano per il Trapianto del Midollo Osseo, and Fred Hutchinson Cancer Research Center collaborative study. Blood. 1999;93:2831-2838.
22. Deeg HJ, Gooley TA, Flowers ME, et al. Allogenic hematopoietic stem cell transplantation for myelofibrosis. Blood. 2003;102:3912-3918.
23. Raghu G, Johnson WC, Lockhart D, et al. Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone: results of a prospective, open-label phase II study. Am J Respir Crit Care Med. 1999;159:1061-1069.
24. Barosi G, Elliot M, Canepa L, et al. Thalidomide in myelofibrosis with myeloid metaplasia: a pooled analysis of individual patient data from 5 studies. Leukemia Lymphoma. 2002;43:2301-2307.